Two new neuroimaging studies shed light on structural and functional abnormalities in the brains of those with major depressive disorder. Read More
Advertisements
The side effects of administering ketamine to treat major depressive disorder are mild and persist for no longer than four hours, researchers report. Most of the side effects peaked within an hour of treatment, and many patients reported the effects as being significantly reduced two hours post ketamine administration. Read More
A polygenetic risk score for major depressive disorder may reveal those most at risk of developing depression during times of extreme stress. Read More
Neurofeedback training can alter guilt-related networks and improve self-esteem in those with major depressive disorder. Read More
Long term outcome data of patients with treatment-resistant depression found subcallosal cingulate deep brain stimulation (SCC DBS) was both effective at relieving symptoms and safe. Read More
Those with anxiety and depressive disorders may actively resist relaxation, especially if they are more sensitive to shifts in negative emotions. Read More
The largest delay discounting effects were found to be associated with bipolar disorder, borderline personality disorder, and schizophrenia. The image is in the public domain. Read More
Poor air quality has been linked to higher rates of bipolar disorder and major depressive disorder. Exposure to air pollution during the first ten years of like is also associated with a more than two-fold increased risk of schizophrenia and personality disorders. Read More
Moderate intensity exercise significantly boosts endocannabinoids and improves mood for those with major depressive disorder. Read More
Only 45% of patients with major depressive disorder find benefit from cognitive behavioral therapy (CBT). A neuroimaging study reveals those who respond to CBT have greater neural activity in the right striatum and right amygdala pretreatment than those who find little benefit from the treatment. The findings could serve as a biomarker to discover who will respond to CBT. Read More
Nineteen gene sets have been identified that contribute to at least five psychiatric disorders. The gene sets were associated with ADHD, ASD, bipolar disorder, major depressive disorder, and schizophrenia. Read More
A potential link has been identified between obstructive sleep apnea (OSA) and major depressive disorder. Treating OSA may help to improve depressive symptoms, as well as reduce suicidal thoughts and improve sleep for those with insomnia. Read More
